Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | ||||||
{[ item.p_purity ]} | {[ item.pr_size ]} | Inquiry |
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price) ]} |
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price) ]} | {[ item.pr_usastock ]} | in stock Inquiry - | {[ item.pr_chinastock ]} | {[ item.pr_remark ]} in stock Inquiry - | Login | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
CAS No. : | 1190392-22-3 | MDL No. : | MFCD20133989 |
Formula : | C8H8N2O3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | VBGNTNJINOCQNQ-YFKPBYRVSA-N |
M.W : | 180.16 | Pubchem ID : | 57907501 |
Synonyms : |
|
Signal Word: | Warning | Class: | |
Precautionary Statements: | P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P330-P363-P501 | UN#: | |
Hazard Statements: | H302-H312-H332 | Packing Group: | |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Stage #1: methyl [6(S)-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-α]]pyrimidine-6-carboxylate With water; lithium hydroxide In tetrahydrofuran; methanol at 20℃; for 1h; Stage #2: With hydrogenchloride In tetrahydrofuran; methanol; water | 5.B Step B: [(6S)-4-oxo-4,6 .8-tetrahydropyrrplo l,2-a]pyrimidine-6-carboxylic acid; Methyl [6(S)-4-oxo-4,6,7f8~tetrahydropyrrolo[ 1 ;2-a]pyrimidine-6-carboxylate (9.95 g, 51.2 mmol) in tetrahydrofuran (60 mL), methanol (40 mL) and a solution of lithium hydroxide (3.32g, 77 mmol) in water (40 mL) was stirred at ambient temperature for 1 h. 2 N hydrochloric acid (38.5 mL) was added to neutralize the reaction mixture which was then directly purified by reverse phase HPLC (TMC Pro-Pac CI 8; 0-40% 0.1 % trifluoroacetic acid in acetonitriie/ 0.1% trifluoroacetic acid in water gradient). The O-alkylation product was eluted fast. The pure fractions were collected and lyophilized overnight afforded the title compound as a pale yellow solid. 3H NMR (DMSO-i¾): δ 7.89 (d, J - 6.6 Hz, 1H), 6.24 (d, J - 6.6 Hz, 1H), 4.92 (dd, J - 10.0, 3.1 Hz, 1H), 3.12-2.99 (m, 2H), 2.52 (m, 1H), 2.11 (m, 1H). LC/MS 181.2 (M+l). | |
Stage #1: methyl [6(S)-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-α]]pyrimidine-6-carboxylate With water; lithium hydroxide In tetrahydrofuran; methanol at 20℃; for 1h; Stage #2: With hydrogenchloride In tetrahydrofuran; methanol; water | B Methyl [6(1?)-4-oxo-4,6,738-tetrahydropyrrolo[lJ2-a]pyrimidine-6-carboxyiate (9.95 g, 51.2 mmol) in tetrahydrofuran (60 mL), methanol (40 mL) and a solution of lithium hydroxide (3.32g, 77 mmol) in water (40 mL) was stirred at ambient temperature for 1 h. 2 N hydrochloric acid (38.5 mL) was added to neutralize the reaction mixture which was then directly purified by reverse phase HPLC (TMC Pro-Pac C18; 0-40% 0.1% trifluoroacetic acid in acetonitrile/0.1% trifluoroacetic acid in water gradient). The O-alkylation product was eluted fast The pure fractions were collected and lyophilized overnight to afford the title compound as a pale yellow solid. lH NMR (DMSO-ifc): δ 7.89 (d, J - 6.6 Hz, 1H), 6.24 (d, J - 6.6 Hz, 1H), 4.92 (dd, J = 10.0, 3.1 Hz, 1H), 3.12-2.99 (m, 2H), 2.52 (m, 1H), 2.11 (m, 1H). LC/MS 181.2 (M+l). | |
Stage #1: methyl [6(S)-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-α]]pyrimidine-6-carboxylate With water; lithium hydroxide In tetrahydrofuran; methanol at 20℃; for 1h; Stage #2: With hydrogenchloride In tetrahydrofuran; methanol; water | 43.B Methyl [6(iS)-4-oxo-4,6s7,8-tetrahydropyrrolo[ 1 ,2-α]pyrimidine-6-carboxylate (9.95 g, 51.2 mmol) from step A in tetrahydrofuran (60 ml), methanol (40 ml) and a solution of lithium hydroxide (3.32g, 77 mmol) in water (40 ml) was stirred at ambient temperature for 1 h. 2 N hydrochloric acid (38.5 ml) was added to neutralize the reaction mixture which was then directly purified by reverse phase ηPLC (TMC Pro-Pac C 18; 0-40% 0.1% trifluoroacetic acid in acetonitrile/ 0.1% trifluoroacetic acid in water gradient). The O-alkylation product was eluted fast. The pure fractions were collected and lyophilized overnight afforded the title compound as a pale yellow solid. 1H NMR (DMSO-d6) δ: 7.89 (d, J= 6.6 Hz, 1H), 6.24 (d, J= 6.6 Viz, 1H), 4.92 (dd, J= 10.0, 3.1 Hz, 1H), 3.12-2.99 (m, 2H)S 2.52 (m, 1H), 2.11 (m, 1H). LC/MS 181.2 (M+l)+. |
Stage #1: methyl [6(S)-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-α]]pyrimidine-6-carboxylate With water; lithium hydroxide In tetrahydrofuran; methanol at 20℃; for 1h; Stage #2: With hydrogenchloride In tetrahydrofuran; methanol; water | 44.B Methyl[6(S)-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-α]pyrimidine-6-carboxylate (9.95 g, 51.2 mmol) in tetrahydrofuran (60 mL), methanol (40 mL) and a solution of lithium hydroxide (3.32 g, 77 mmol) in water (40 mL) was stirred at ambient temperature for 1 h. 2 N hydrochloric acid (38.5 mL) was added to neutralize the reaction mixture which was then directly purified by reverse phase HPLC (TMC Pro-Pac C18; 0-40% 0.1% trifluoroacetic acid in acetonitrile/0.1% trifluoroacetic acid in water gradient). The O-alkylation product was eluted fast. The pure fractions were collected and lyophilized overnight to afford the title compound as a pale yellow solid. 1H NMR (DMSO-d6): δ 7.89 (d, J=6.6 Hz, 1H), 6.24 (d, J=6.6 Hz, 1H), 4.92 (dd, J=10.0, 3.1 Hz, 1H), 3.12-2.99 (m, 2H), 2.52 (m, 1H), 2.11 (m, 1H). LC/MS 181.2 (M+1). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: 110 °C 2: water; lithium hydroxide / tetrahydrofuran; methanol / 1 h / 20 °C | ||
Multi-step reaction with 2 steps 1: 110 °C 2: water; lithium hydroxide / tetrahydrofuran; methanol / 1 h / 20 °C | ||
Multi-step reaction with 2 steps 1: 110 °C 2: water; lithium hydroxide / tetrahydrofuran; methanol / 1 h / 20 °C |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
72% | With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 0 - 20℃; for 2h; | A To a solution of i-13a (21.4 g, 55.9 mmol) in N,N-dimethylformamide (100 ml) at 0 °C was added [(6iS)-4-oxo-4s6,7,8-tetrahydropyrrolo[is2-a]pyrimidine-6-carboxyUc acid (i-44, 11.1 g, 61.5 mmol), followed by 1-hydroxybenzotriazole (7.55 g, 55.9 mrnol), N-(3- dimethylaminopropyl)-A^-ethylcarbodiimide hydrochloride (16.1 gs 84.0 mmol) and NtN- diisopropylethyiamine (29.2 ml, 168 mmol). The reaction mixture was stirred from 0 °C to ambient temperature for 2 h. Water (600 ml) was added and it was extracted withdichloromethane (600 ml x 2). The combined organic layers were dried over Na2S04. After removal of the volatiles, the residue was purified by using a Biotage Horizon system (0-5% then 5% methanol with 10% ammonia/dichloromethane mixture) to afford the title compound which contained 8% of the minor diastereomer. It was further purified by supercritical fluid chromatography (chiral AS column, 40% methanol) to afford the -title compound as a pale yellow solid (22.0 g, 72%). 1H NM (CDC13): 6 9.61 (s, 1H), 7.93 (d, -J = 6:6 Hz, 1H), 7.49 (d, J = 8.4 Hz, 2H), 7.35-7.28 (m, 5H)S 7.13 (d, J = 8.5 Hz, 2H), 6.40 (d, J = 6.7 Hz, 1H)5 5.36 (d, J - 8.6 Hz, 1H), 4.38 (m, 1H)S 4.12-4.04 (m, 2H), 3.46 (m,lH), 3.15-3.06 (m, 2H), 2.91 (dd> J - 13.1, 9.0 Hz, 1H), 2.55 (m, 1H), 2.38 (m, 1H), 1.71-1.49 (m, 13H). LC-MS 567.4 (M+23). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: 0.75 h / 150 °C 2: water; lithium hydroxide / tetrahydrofuran; methanol / 1 h / 20 °C | ||
Multi-step reaction with 2 steps 1: 0.75 h / 150 °C 2: water; lithium hydroxide / tetrahydrofuran; methanol / 1 h / 20 °C |